SMERUD LEGAL AND REGULATORY AS
Home | SMERUD MEDICAL RESEARCH INTERNATIONAL AS
SMERUD, a leading CRO, offers full-service clinical solutions to biotech, pharma, med-tech & academic sponsors.
Links
Organization
- CEO
- KT
- Chairman of the board
- KT
- Years since formation
- 18 years
- since Aug 2, 2007
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 2
- companies
- Belongs to group of
Financials
- Annual total result 2024
- -39,770
- NOK
- Total equity 2024
- -1,046,326
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
KT | Managing Director/CEO | 100 % indirectly |
Board
Name | Role | Shares |
---|---|---|
KT | Chairman | 100 % indirectly |
HK | Alternate Member | - |
Others
Name | Role | Shares |
---|---|---|
Accountant | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
KT | Managing Director/CEO, Chairman | 100 % indirectly |
Last update: Apr 13, 2023
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 990 | 99 % | |
Ordinary shares | 10 | 1 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -95,650Employees: 0
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 301,820 |
Annual Total Result | -39,770 | -7,573 | -11,762 | 211,113 |
Total assets | 263,070 | 302,840 | 310,413 | 381,720 |
Total liabilities | 1,309,396 | 1,309,396 | 1,309,396 | 1,368,941 |
Total equity | -1,046,326 | -1,006,556 | -998,983 | -987,221 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 301,820 |
Total operating costs | 39,770 | 8,856 | 11,577 | 31,162 |
Operating result | -39,770 | -8,856 | -11,577 | 270,658 |
Financial income/costs | 0 | 1,283 | -185 | 0 |
Profit before tax | -39,770 | -7,573 | -11,762 | 270,658 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 59,545 |
Annual Total Result | -39,770 | -7,573 | -11,762 | 211,113 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 263,070 | 302,840 | 310,413 | 381,720 |
Total assets | 263,070 | 302,840 | 310,413 | 381,720 |
Short term debt | 1,309,396 | 1,309,396 | 1,309,396 | 1,368,941 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 1,309,396 | 1,309,396 | 1,309,396 | 1,368,941 |
Contributed capital | 628,189 | 628,189 | 628,189 | 628,189 |
Retained earnings | -1,674,515 | -1,634,745 | -1,627,172 | -1,615,410 |
Total equity | -1,046,326 | -1,006,556 | -998,983 | -987,221 |
Total equity and liabilities | 263,070 | 302,840 | 310,413 | 381,720 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises